相似文献
1
Response to Letter from Dr. Volbeda and Colleagues Regarding COVID-19 and CKD.
Kidney Int Rep. 2023 Jul 30;8(9):1900-1901. doi: 10.1016/j.ekir.2023.07.015. eCollection 2023 Sep.
2
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.
Pregnancy Hypertens. 2022 Mar;27:94-95. doi: 10.1016/j.preghy.2021.11.002. Epub 2021 Nov 25.
3
Response to commentary 'long COVID-19/post-COVID condition in children: do we all speak the same language?
Ital J Pediatr. 2022 Dec 19;48(1):200. doi: 10.1186/s13052-022-01394-4.
4
Reply to the Letter to the Editor from Dr. Seet-Lee and Colleagues.
Int J Sports Med. 2022 Mar;43(3):288. doi: 10.1055/a-1754-3377. Epub 2022 Mar 1.
5
The above letter was sent to Dr Mota et al.: Dr Mota and colleagues offered the following reply.
Transfusion. 2006 Jun;46(6):1062-3. doi: 10.1111/j.1537-2995.2006.00848.x.
6
Response to the letter from Dr. Kim and colleagues.
Psychiatry Res. 2018 May;263:291-292. doi: 10.1016/j.psychres.2018.03.040. Epub 2018 Mar 29.
7
Response to Letter to the Editor by Dr Kobayashi and Colleagues.
J Card Fail. 2019 Feb;25(2):141. doi: 10.1016/j.cardfail.2019.01.001. Epub 2019 Jan 7.
8
Response to Dr. Buschard and Colleagues' Letter to the Editor: Sulfatide and Longevity.
J Gerontol A Biol Sci Med Sci. 2022 Sep 1;77(9):1717-1718. doi: 10.1093/gerona/glac125.
9
Response to the letter from Dr. Veerman and colleagues.
Psychopharmacology (Berl). 2017 Dec;234(23-24):3537-3538. doi: 10.1007/s00213-017-4757-8. Epub 2017 Oct 7.
10
Diabetic Retinopathy as a Risk Factor for Chronic Kidney Disease Progression: A Multicenter Case⁻Control Study in Taiwan.
Nutrients. 2019 Feb 27;11(3):509. doi: 10.3390/nu11030509.
本文引用的文献
1
Risk factors for severe COVID-19 in the young-before and after ICU admission.
Ann Intensive Care. 2023 Apr 25;13(1):31. doi: 10.1186/s13613-023-01127-8.
2
Association Between CKD, Obesity, Cardiometabolic Risk Factors, and Severe COVID-19 Outcomes.
Kidney Int Rep. 2023 Apr;8(4):775-784. doi: 10.1016/j.ekir.2023.01.010. Epub 2023 Jan 14.
3
Acute and chronic histopathological findings in renal biopsies in COVID-19.
Clin Exp Med. 2023 Aug;23(4):1003-1014. doi: 10.1007/s10238-022-00941-x. Epub 2022 Nov 18.
4
Coding practice in national and regional kidney biopsy registries.
BMC Nephrol. 2021 May 24;22(1):193. doi: 10.1186/s12882-021-02365-3.
Zotero 插件